You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Patent: 10,227,383


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,227,383
Title:Specific modification of antibody with IgG-binding peptide
Abstract: This invention relates to an IgG-binding peptide, an IgG-binding peptide modified with a cross-linking agent, a conjugate of the IgG-binding peptide modified with a cross-linking agent and IgG, and a method for producing the conjugate, etc.
Inventor(s): Ito; Yuji (Kagoshima, JP)
Assignee: Kagoshima University (Kagoshima, JP)
Application Number:15/575,138
Patent Claims:see list of patent claims

Details for Patent 10,227,383

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Ag CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN immune globulin intravenous (human) For Injection 102367 07/27/2000 ⤷  Try a Trial 2035-05-20
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 07/26/2007 ⤷  Try a Trial 2035-05-20
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 10/02/2009 ⤷  Try a Trial 2035-05-20
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 02/07/2013 ⤷  Try a Trial 2035-05-20
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 09/17/2009 ⤷  Try a Trial 2035-05-20
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 02/06/2017 ⤷  Try a Trial 2035-05-20
Csl Behring Ag HIZENTRA immune globulin subcutaneous (human), 20% liquid Injection 125350 03/04/2010 ⤷  Try a Trial 2035-05-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.